EUGIA PHARMA Company Profile
✉ Email this page to a colleague
What is the competitive landscape for EUGIA PHARMA, and what generic alternatives to EUGIA PHARMA drugs are available?
EUGIA PHARMA has one hundred and sixty-nine approved drugs.
There is one US patent protecting EUGIA PHARMA drugs. There are three tentative approvals on EUGIA PHARMA drugs.
There are ten patent family members on EUGIA PHARMA drugs in nine countries and three hundred and fifty-one supplementary protection certificates in eighteen countries.
Summary for EUGIA PHARMA
| International Patents: | 10 |
| US Patents: | 1 |
| Tradenames: | 143 |
| Ingredients: | 135 |
| NDAs: | 169 |
| Patent Litigation for EUGIA PHARMA: | See patent lawsuits for EUGIA PHARMA |
Drugs and US Patents for EUGIA PHARMA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eugia Pharma | CAFFEINE CITRATE | caffeine citrate | SOLUTION;INTRAVENOUS | 205013-001 | Sep 22, 2015 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Eugia Pharma | GRANISETRON HYDROCHLORIDE | granisetron hydrochloride | INJECTABLE;INJECTION | 204238-001 | Jul 6, 2016 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Eugia Pharma Speclts | FLUOROURACIL | fluorouracil | INJECTABLE;INJECTION | 202668-001 | Jul 17, 2012 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Eugia Pharma | ESOMEPRAZOLE SODIUM | esomeprazole sodium | INJECTABLE;INTRAVENOUS | 204657-002 | Aug 10, 2016 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Eugia Pharma | LETROZOLE | letrozole | TABLET;ORAL | 211717-001 | Jan 11, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Eugia Pharma Speclts | AMPICILLIN SODIUM | ampicillin sodium | INJECTABLE;INJECTION | 065499-001 | Aug 17, 2010 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for EUGIA PHARMA Drugs
Supplementary Protection Certificates for EUGIA PHARMA Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1667986 | 28/2013 | Austria | ⤷ Sign Up | PRODUCT NAME: DIMETHOXYDOCETAXEL-ACETONSOLVAT (CABAZITAXEL-ACETONSOLVAT); REGISTRATION NO/DATE: EU/1/11/676/001 20110317 |
| 0257344 | SPC/GB98/043 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: DIPYRIDAMOLE, OPTIONALLY IN THE FORM OF A PHYSIOLOGICALLY ACCEPTABLE SALT, AND O-ACETYLSALICYLIC ACID, OPTIONALLY IN THE FORM OF A PHYSIOLOGICALLY SALT, I.E. ASASANTIN RETARD; REGISTERED: FR NL 22160 19970709; UK 00015/0224 19980512 |
| 2603514 | CA 2019 00015 | Denmark | ⤷ Sign Up | PRODUCT NAME: EN KOMBINATION AF VABORBACTAM, OG/ELLER ET SALT OG/ELLER HYDRAT DERAF, OG MEROPENEM, OG/ELLER ET SALT OG/ELLER HYDRAT DERAF, SAERLIGT MEROPENEM TRIHYDRAT; REG. NO/DATE: EU/1/18/1334 20181122 |
| 0463756 | 99C0007 | Belgium | ⤷ Sign Up | PRODUCT NAME: SILDENAFIL, NATL REGISTRATION NO/DATE: EU/1/98/077/001 19980914; FIRST REGISTRATION: CH 54642 19980622 |
| 1189916 | 2011C/004 | Belgium | ⤷ Sign Up | PRODUCT NAME: REGADENOSON; AUTHORISATION NUMBER AND DATE: EU/1/10/643/001 20100906 |
| 2603514 | C02603514/02 | Switzerland | ⤷ Sign Up | PRODUCT NAME: VABORBACTAM UND MEROPENEM; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 67797 01.07.2021 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
